Paul Duncan
Psychiatric/Mental Health · Jeffersonville, INNPI 1841852118
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,825 of the $46,018 with a category attached, or 82.2%. AbbVie accounts for 89.5% of it on its own, with 18 other manufacturers making up the rest. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 584 payments — averaging $78.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$41K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Neurocrine Biosciences, Inc.$421
- Johnson & Johnson$358
- Lundbeck LLC$325
- Vanda Pharmaceuticals Inc.$312
- plus $2K from 13 others
What the payments were for
- Speaking & faculty fees$37,82582%
- Food & beverage$8,13418%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 275 | $41,176 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 104 | $1,538 |
| Neurocrine Biosciences, Inc. | 33 | $421 |
| Johnson & Johnson | 23 | $358 |
| Lundbeck LLC | 21 | $325 |
| Vanda Pharmaceuticals Inc. | 16 | $312 |
| Sunovion Pharmaceuticals Inc. | 19 | $300 |
| Teva Pharmaceuticals USA, Inc. | 16 | $296 |
| Alkermes, Inc. | 16 | $292 |
| Otsuka America Pharmaceutical, Inc. | 16 | $259 |
| Indivior Inc. | 10 | $176 |
| Axsome Therapeutics, Inc. | 11 | $170 |
| Almatica Pharma LLC | 6 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $78 |
| Noven Therapeutics, LLC | 4 | $76 |
| E.r. Squibb & Sons, L.L.C. | 3 | $62 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Neuronetics, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$38,781
How this compares
$46,018 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 193 | $285,520 |
| Invega SustennaPaliperidone Palmitate | 61 | $170,559 |
| Abilify MaintenaAripiprazole | 22 | $58,751 |
| LybalviOlanzapine/Samidorphan Malate | 36 | $56,029 |
| RexultiBrexpiprazole | 36 | $50,675 |
| AristadaAripiprazole Lauroxil | 12 | $38,284 |
| TrintellixVortioxetine Hydrobromide | 59 | $27,989 |
| AuvelityDextromethorphan Hbr/Bupropion | 24 | $18,740 |
| SpravatoEsketamine Hcl | 21 | $17,906 |
| Clozapine OdtClozapine | 24 | $13,856 |
| Clozapine | 141 | $12,007 |
| Aripiprazole | 89 | $11,229 |
| Paliperidone ErPaliperidone | 29 | $8,296 |
| Atomoxetine Hcl | 26 | $4,883 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 33 | $3,304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $41,176 | $285,520193 claims |
| Johnson & JohnsonInvega Sustenna, Spravato | $358 | $188,46482 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $259 | $109,42558 claims |
| Alkermes, Inc.Lybalvi, Aristada | $292 | $94,31348 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $78 | $27,98959 claims |
| Axsome Therapeutics, Inc.Auvelity | $170 | $18,74024 claims |
| Almatica Pharma LLCSertraline Hcl | $104 | $55880 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Other psychiatric/mental health in Jeffersonville
- Anthony AemmerJeffersonville$9K
- Matthew CulbrethJeffersonville$7K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
- Savannah MullinsClarksville$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.